Furthermore, it was found that NSCLC cells that were resistant to paclitaxel, a chemotherapeutic agent used in the treatment of lung cancer, had decreased FNDC5 levels, and irisin treatment was able to attenuate this chemoresistance [81]. This evidence concerns the gene FNDC5 and non-small cell lung carcinoma.